TrEatment Approach in the Multimodal Era Registry (NCT05629052)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this observational patient registry is to learn how expert centers treat patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition in which blood clots block the blood vessels in the lungs. There are currently three treatment options for patients with CTEPH: * surgery to remove blood clots from large vessels in the lungs (pulmonary endarterectomy (PEA)) * the use of a small balloon to unblock smaller blood vessels (balloon pulmonary angioplasty (BPA)) * drugs Patients can also receive a combination of these treatments. The main question this registry aims to answer are: * How many patients receive a given kind of treatment? * How do expert centers combine the different treatments? * Are patients doing better after they receive a given kind of treatment? * How many patients are alive 1, 3 and 5 years after they receive a given kind of treatment? Participants will receive the same treatments that they would receive if they did not participate in the study. During the study, patients will visit their doctors as they would do normally. The doctors will collect information on the patients' health and enter it into the study database. The follow-up time will be at least 3 years for all patients.
Who can join: Review the eligibility criteria below.
Location: University of California San Diego — San Diego, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (25 Sites)
- University of California San Diego — San Diego, California
- Northwestern University — Evanston, Illinois
- Duke University — Durham, North Carolina
- UT Southwestern — Dallas, Texas
- Hospital Universitario Fundación Favaloro — Buenos Aires,
- University Hospital Vienna — Vienna,
- University Hospitals Leuven — Leuven,
- Santa Casa — Porto Alegre,
- Toronto General Hospital — Toronto, Ontario
- China-Japan Friendship Hospital — Beijing,
- Shaio Clinic Foundation — Bogotá,
- General University Hospital — Prague,
- Aarhus University Hospital — Aarhus,
- Kerckhoff Clinic, Department of Thoracic Surgery — Bad Nauheim,
- Narayana Institute of Cardiac Science — Bangalore,
- University of Bologna — Bologna,
- Okayama Medical Center — Okayama,
- National Cerebral and Cardiovascular Center — Osaka,
- National Heart Institute — Mexico City,
- Department of Cardiac and Vascular Diseases, John Paul II Hospital — Krakow,
- Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, European Health Center Otwock — Otwock,
- National Heart Centre of Singapore — Singapore,
- Pulmonary Hypertension Unit, Hospital 12 de Octubre — Madrid,
- Marmara University School of Medicine — Istanbul,
- Royal Papworth Hospital — Cambridge,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Thromboembolic Pulmonary Hypertension
- Chronic Thromboembolic Disease Registry — San Francisco, California
Explore by condition: All Chronic Thromboembolic Pulmonary Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.